NCT03374826View on ClinicalTrials.gov

PET-MRI for Axillary Staging in Node Negative Breast Cancer Patients

NARecruitingINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

February 22, 2018

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Breast CancerBreast NeoplasmsBreast Diseases
Interventions
DIAGNOSTIC_TEST

Dedicated axillary hybrid PET-MRI

All clinically node negative patients will undergo a hybrid PET-MRI axilla preoperatively, followed by breast surgery and SLNB.

Trial Locations (2)

Unknown

RECRUITING

Maastricht University Medical Center, Maastricht

3015GD

RECRUITING

Erasmus Medical Center, Rotterdam

Sponsors

Collaborators (1)

Erasmus Medical Center
All Listed Sponsors
collaborator

Erasmus Medical Center

OTHER

lead

Maastricht University Medical Center

OTHER

NCT03374826 - PET-MRI for Axillary Staging in Node Negative Breast Cancer Patients | Biotech Hunter | Biotech Hunter